Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

Dec 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2651)	4/26/2010 12:57:51 PM
From: Jibacoa	Read Replies (2) of 3722

BCRX is holding above the support at the $7.25 level, while waiting for the report of its 1stQ results on Wednesday.<g> The 4thQ results came out much better than expected.<g> Revenues were up 60% and earnings 35% compared to the 2008 4thQ and in spite of the poor showing in the 3rdQ <g> On Apr5 Thomson Reuters downgraded it from buy to hold.<g> At its coming annual meeting in May, BCRX expects to increase by another 1.3M the number of shrs outstanding.<g> The ACTAY is $9.88 It seems that with some good news the stock could get to the $10 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next